Renaissance Technologies’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
2019
Q3
$2.22M Buy
2019
Q2
$1.62M Buy
2019
Q1
$454K Sell
2018
Q4
$761K Buy
2018
Q3
Sell
2018
Q2
$692K Sell
2018
Q1
$871K Buy
2017
Q4
$1.3M Buy